Unlocking the potential of engineered immune cell therapy for solid tumors
Author
Date
2025-01-29Permanent link
http://hdl.handle.net/11351/12860DOI
10.1038/s41467-025-56527-0
ISSN
2041-1723
WOS
001410925600007
PMID
39880825
Abstract
Adoptive cell therapy has emerged as a promising approach for treating advanced solid malignancies. Genetic engineering techniques represent an exciting area of research for the development of cellular products with enhanced cytotoxicity, phenotype, and metabolism.
Keywords
Immune cell therapy; Solid tumorsBibliographic citation
Albarrán-Fernández V, Angelats L, Delgado J, Gros A, Urbano-Ispizua Á, Guedan S, et al. Unlocking the potential of engineered immune cell therapy for solid tumors. Nat Commun. 2025 Jan 29;16:1144.
Audience
Professionals
This item appears in following collections
- VHIO - Articles científics [1250]
The following license files are associated with this item:





